Your browser doesn't support javascript.
loading
Structural and Socio-Spatial Determinants Influencing Care and Survival of Patients with a Pancreatic Adenocarcinoma: Results of the PANDAURA Cohort.
Roth, Gaël S; Fayet, Yohan; Benmameche-Medjahed, Sakina; Ducimetière, Françoise; Charreton, Amandine; Cropet, Claire; Chabaud, Sylvie; Marion-Audibert, Anne-Marie; Berthelet, Olivier; Walter, Thomas; Adham, Mustapha; Baconnier, Mathieu; Tavan, David; Williet, Nicolas; Artru, Pascal; Huet-Penz, Floriane; Ray-Coquard, Isabelle; Farsi, Fadila; Labrosse, Hélène; de la Fouchardière, Christelle.
Afiliação
  • Roth GS; University Grenoble Alpes/Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes/Institute for Advanced Biosciences, CNRS UMR 5309-INSERM U1209, 38043 Grenoble, France.
  • Fayet Y; Research on Healthcare Performance (RESHAPE), INSERM U1290, Equipe EMS-Social and Human Sciences Department, Centre Léon Bérard, 69008 Lyon, France.
  • Benmameche-Medjahed S; Medical Oncology Department, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
  • Ducimetière F; Medical Oncology Department, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
  • Charreton A; Medical Oncology Department, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
  • Cropet C; Biostatistics Deparment, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
  • Chabaud S; Biostatistics Deparment, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
  • Marion-Audibert AM; Gastroenterology and Hepatology, Clinique du Val d'Ouest, 39 Chemin de la Vernique, 69130 Ecully, France.
  • Berthelet O; Hepato-Gastroenterology Department, Centre Hospitalier Métropole Savoie, 73011 Chambery, France.
  • Walter T; Medical Oncology Department, Hopital Edouard Herriot, 69003 Lyon, France.
  • Adham M; Surgery Department, Hopital Edouard Herriot, 69003 Lyon, France.
  • Baconnier M; Hépatogastroenterology Department, Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.
  • Tavan D; Hépatogastroentérology Department, Infirmerie Protestante, 69300 Caluire-et-Cuire, France.
  • Williet N; Hepatogastroenterology and Digestive oncology Department, University Hospital of Saint-Etienne, 42270 Saint-Priest-en-Jarez, France.
  • Artru P; Gastroenterology Department, Hopital privé Jean Mermoz, 69008 Lyon, France.
  • Huet-Penz F; Hepato-Gastroenterologie, Centre Hospitalier Alpes Léman, 74130 Contamine sur Arve, France.
  • Ray-Coquard I; Medical Oncology Department, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
  • Farsi F; ONCOAURA, Dispositif Spécifique Régional de Cancérologie, 60 Avenue Rockefeller, 69008 Lyon, France.
  • Labrosse H; ONCOAURA, Dispositif Spécifique Régional de Cancérologie, 60 Avenue Rockefeller, 69008 Lyon, France.
  • de la Fouchardière C; Medical Oncology Department, Centre Léon Bérard/Research Center of Lyon (CRCL), UMR INSERM 1052, 28 rue Laennec, 69008 Lyon, France.
Cancers (Basel) ; 14(21)2022 Nov 03.
Article em En | MEDLINE | ID: mdl-36358831
ABSTRACT
Background and

aims:

Pancreatic cancer is highly lethal and often diagnosed at an advanced stage. This cohort study analyzes the impact of care pathways, delays, and socio-spatial determinants on pancreatic cancer patients' diagnosis, treatment, and prognosis.

Method:

Patients with pancreatic adenocarcinoma newly diagnosed at all stages between January and June 2016 in the AuRA French region were included. The influence on survival of delays of care, healthcare centers' expertise, and socio-spatial determinants was evaluated.

Results:

Here, 538 patients were included in 76 centers including 116 patients (21.8%) with resectable, 64 (12.0%) borderline-resectable, 147 (27.6%) locally-advanced tumors, and 205 (38.5%) with metastatic disease. A delay between first symptoms and CT scans did not statistically influence overall survival (OS). In resected patients, OS was significantly higher in centers with more than 20 surgeries (HR<5 surgeries/year = 2.236 and HR5-20 surgeries/year = 1.215 versus centers with > 20 surgeries/year p = 0.0081). Regarding socio-spatial determinants, patients living in municipalities with greater access to a general practitioner (HR = 1.673, p = 0.0153) or with a population density below 795.1 people/km2 (HR = 1.881, p = 0.0057) were significantly more often resectable.

Conclusion:

This cohort study supports the pivotal role of general practitioner in cancer care and the importance of the centralization of pancreatic surgery to optimize pancreatic cancer patients' care and outcomes. However, delays of care did not impact patient survival.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article